Allogeneic Transplant: Durable Remissions in T-Cell Lymphomas ...Middle East

Medscape - News
Five-year progression-free survival approached 40% and 5-year overall survival was over 50% in the study. Treatment-related mortality ranged from about 8% to 24%, depending on the donor type. Medscape Medical News

Hence then, the article about allogeneic transplant durable remissions in t cell lymphomas was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Allogeneic Transplant: Durable Remissions in T-Cell Lymphomas )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News